Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Rothenberger

Showing results (91-100 of 92) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 92 results.
Pediatric Transplantation|January 8, 2025
Association Between Early Immunosuppression Center Variability and One-Year Outcomes After Pediatric Liver TransplantVikram K Raghu, Scott D Rothenberger, James E Squires, et al.
The Lancet. Haematology|June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trialMargaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
Pageof 10

Showing results (91-100 of 92) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 92 results.
Pediatric Transplantation|January 8, 2025
Association Between Early Immunosuppression Center Variability and One-Year Outcomes After Pediatric Liver TransplantVikram K Raghu, Scott D Rothenberger, James E Squires, et al.
The Lancet. Haematology|June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trialMargaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
Pageof 10